| INTRODUCTION
High-affinity antibodies arise to fight infections and as a response to vaccinations; therefore, they are an essential part of our immune system. Affinity of antibodies matures in germinal centres (GCs) of secondary lymphoid follicles, where accumulative cycles of somatic hypermutation (SHM) and selection of proliferating activated B cells eventually lead to improved antibodies with higher affinity for antigen. 1 Upon antigen encounter, B cells differen-high-affinity antibody-secreting cell generation, and the risks associated with this process, it is important to understand how the transition of B cells into ASCs is regulated at genetic level. Differentiation of B cells into ASCs is controlled by a complex hierarchical network of transcription factors. Within this network, transcription factors PAX5, BCL6, IRF8 and BACH2 promote B cell gene expression programme in GC and prevent premature differentiation into ASCs.
1,2,4,5 IRF4 and BLIMP-1 promote the initiation of ASC gene expression programme, and later during the differentiation, XBP1 is needed for unfolded protein response and ELL2 for the expression of secretory form of IgH.
1,2,6-8 IRF4 appears to have a dual role, as a low level of IRF4 expression induces BCL6 expression and GC reaction, whereas high level of IRF4 promotes the expression of PRDM1 (the gene-encoding BLIMP-1). 9 High IRF4
expression together with Blimp-1 suppresses B cell phenotype. 9, 10 Studies with Irf4-deficient mice suggested that restoration of Prdm1 expression in activated Irf4 À/À B cells is sufficient to promote immunoglobulin (Ig) secretion. 9 However, another study indicated that Prdm1 expression in the absence of IRF4 was insufficient for plasma cell differentiation or Ig secretion, and that the roles of IRF4 and BLIMP-1 were non-redundant for antibody secretion.
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Recent studies in mice with a conditional deletion of Prdm1 in plasma cells have shown that BLIMP-1 regulates various genes involved in antibody secretion but was unable to reverse the plasmacytic identity. 12, 13 Conditional Irf4 deletion in plasma cells resulted in cell death and IRF4 was concluded to be mostly needed for survival of plasma cells rather than for Ig secretion phenotype. 13 Considering that many aspects regarding the role of IRF4 in the regulation of antibody secretion still remain unclear, and that Irf4-deficient mouse plasma cells are nonviable, 13 we used another model to study the role of IRF4 in antibody secretion in DT40 B cell line. We reasoned that immortalized DT40 cells overexpressing MYC would allow to more precisely dissect the roles of IRF4 and BLIMP-1 in antibody secretion. This cell line is derived from chicken bursal follicles, where BCL6 and BACH2 are required for somatic hypermutation and gene conversion. 14, 15 We have previously shown that deletion of PAX5 or BCL6 in these cells leads to spontaneous upregulation of PRDM1 and differentiation into early ASC phenotype. 4, 16 In this study, we tested whether IRF4 is needed for antibody secretion and PRDM1 expression. Therefore, we created IRF4
À/À double knockout cell line (DKO).
We found that in the absence of IRF4, the deletion of BCL6 did not induce PRDM1 expression and antibody secretion. Surprisingly, the overexpression of PRDM1 was able to induce antibody secretion only in WT cells and not in IRF4KO or DKO cells. Thus, our results demonstrate that BLIMP-1 is insufficient to induce antibody secretion in the absence of IRF4 in DT40 B cells.
| MATERIALS AND METHODS

| Generation of IRF4
À/À/À /BCL6 À/À double knockout (DKO) cell line and culture conditions
To obtain DKO cell line, the BCL6-encoding alleles were removed with previously described targeting vectors 4 from IRF4-deficient cell line (IRF4KO). 17 The DT40 cell line carries three alleles of IRF4 due to trisomy of IRF4 harbouring chromosome 2. 18 Prior to the targeting of BCL6, the expression vector Mer-Cre-Mer-Puro 19 was stably transfected into IRF4KO cells to allow p-lox-mediated removal of Bsr and Neo selection cassettes. The IRF4KO cells were induced with 1.29 mmol/L (Z)-4-Hydroxytamoxifen (Sigma) for 3 days as described in. 20 After that, cells were single cell subcloned and clone with removed Bsr, Neo and Puro selection cassettes was used for further experiments. The absence of IRF4 and BCL6 expression was confirmed by Western blot analysis ( Figure 1A ) and by RT-qPCR ( Figure 1B ), respectively. DT40 WT, BCL6KO, IRF4KO and DKO cells were cultured in RPMI 1640 (Sigma life technologies) supplemented with 10% foetal calf serum (Hyclone), 1% chicken serum (BioWest), 50 lmol/L b-mercaptoethanol, 1 x GlutaMax-I (Gibco) and 1x penicillin-streptomycin (Gibco) in a humidified atmosphere with 5% CO 2 at +40°C.
| Western blot analysis
DT40 cells were lysed with RIPA buffer (150 mmol/L NaCl, 5 mmol/L EDTA (pH 8.0), 1% NP-40, 0.5% sodium deoxycholate and 0.1% SDS) supplemented with 1x protease inhibitor cocktail (cOmplete tablets, Roche). The whole cell lysates were separated on SDS-PAGE gels, transferred onto nitrocellulose membrane with eBlot Protein Transfer system (Gene Script) and detected by Odyssey FC system (Li-Cor Biosciences). Antibodies used in study: anti-IRF4 (M-17) (Sc-6059, Santa Cruz Biotechnology), anti-GAPDH mAb (4G5, Hytest), anti-chicken IgM (A30-102A, Bethyl Laboratories, Inc.), Li-COR IRDye 800CW donkey anti-goat (#926-32214) and goat anti-mouse (#926-32210). analysed by one-way ANOVA with Holm-Sidak's post-test where each cell type was compared to WT cell line. *P < .05, **P < .01, ***P < .001, ****P < .0001; ns, not statistically significant; nd, not detected
| RT-qPCR analysis
| Measurement of cell proliferation
The cell proliferation was performed using carboxyfluorescein succinimidyl ester (CFSE) staining as previously described. 15 Briefly, WT, IRF4KO, DKO and BCL6KO cells were stained with 0.5 lmol/L (CFSE; Invitrogen). CFSElabelled cells were cultured for 65 hours and followed with flow cytometer at time points indicated in Figure S1 .
| ELISA analysis
For the ELISA assay, 10 6 cells were grown in 1 mL of DT40 medium without chicken serum for 24 hour in humidified atmosphere with 5% CO 2 at +40°C. The medium containing secreted IgM was collected from two independent cultures (two biological repeats) per sample and used in a dilution of 1:10 or 1:100 in duplicates for the analysis with the chicken IgM ELISA kit (E33-102, Bethyl Laboratories, Inc.) in accordance to the manufacturer's instructions. The absorbance was measured on an ELISA plate reader (Multiscan EX, Thermo Electron Corporation) at 450 nm, and the amount of chicken IgM in unknown samples was calculated from standard curve with curve-fitting software GraphPad Prism version 7.01.
| Gene expression array
Total RNA was isolated as described in RT-qPCR section. RNAs were isolated from 2 (BCL6KO) or 3 (WT, IRF4KO, DKO) independent cultures. Sample preparation was performed with Agilent's Low Input Quick Amp Labeling Kit (one-colour) using 200 ng of total RNA as starting material and samples were hybridized onto Agilent's 4x 44K Chicken V2 chip according to the manufacturer's instructions. Arrays were scanned with Agilent technologies Scanner and numerical results extracted with Feature Extraction version 10.7.1. The data were analysed using R/Bioconductor tool (Bioconductor version 2.7, R version 2.12.0). Data were quantile normalized and a comprehensive quality analysis was performed. Limma package was used for statistical testing and cut-off values of false discovery rate below 0.01 and absolute fold change above 2 used to filter differentially expressed genes. 
| PRDM1 and IRF4 expression constructs
Schematic presentation of expression constructs is presented on Figure 3A and Figure 4A and Figure S3A . Chicken PRDM1 coding sequence was amplified from BCL6KO DT40 cDNA using primers Blimp1_F ATTCACCACAGC TAGATGAAGGCTGCTACACGGTGTAGC and Blimp1_linker_R CTACTCCCAGCTGCACTACCTCCAGGGT CCATTGGTTCAACTGT or Blimp1_R TCCAGGGTC CATTGGTTCAACTGTT for B1-GFP or B1-T2A-GFP expression construct, respectively. The primers create linker sequence GGTAGTGCAGCTGGGAGTAGCGGT between PRDM1 and EGFP coding sequence in B1-GFP construct. Chicken IRF4 was amplified from WT DT40 cDNA using primers IRF4_F ATTCACCACAGCTAGATGAACTTG GAGCCGGG-TGAG and IRF4_R TTCTTGAATAGAG GAATGGCGAATAGATCTGTGA.
| Infection of cells by lentiviral constructs
The 293T cells were cotransfected with the psPAX2 and pMD2.G packaging vectors and B1-GFP (p-lenti-RSV-B1/ GFP-IRES-PURO), GFP Mock, IRF4 mC (p-lenti-RSV-IRF4-T2AmCherry-IRES-GPT) or mC Mock expression plasmids using X-treme GENE HP DNA transfection Reagent (Roche) according to the manufacturer's instructions. Three days after transfection, viral supernatants were harvested. 
/BCL6
À/À DKO cell line by disrupting BCL6 in IRF4KO cells. The resulting DKO cells were verified to lack both the IRF4 and BCL6 expression (Figure 1A,B) . BCL6 and IRF4 single knockouts were described previously. 4, 17 The DKO cell line had the same growth characteristics as IRF4 single knockout and WT cell lines ( Figure S1 ). As BCL6KO cells secrete antibodies, 4 we analysed whether DKO cells lacking both IRF4
and BCL6 also secrete. DT40 cells do not undergo isotype switching. Therefore, we measured IgM from supernatants of WT, IRF4KO, DKO and BCL6KO cell cultures. DKO cells did not secrete more antibodies than WT cells (Figure 1C) . Thus, removal of BCL6 is insufficient to induce antibody secretion in the absence of IRF4. As BLIMP-1 drives the antibody secretion, 12, 13 and that IRF4 upregulates PRDM1 expression, 9 we analysed the expression of PRDM1 ( Figure 1D ). PRDM1 expression was not upregulated in either IRF4KO or DKO cells while BCL6KO cells had high PRDM1 expression. This indicates that PRDM1 expression correlates with antibody secretion. We also analysed whether the BCL6 and IRF4 deficiency would affect the expression levels of PRDM1 repressors BACH2, IRF8 and PAX5. 16, 21, 22 Removal of IRF4 alone increased their expression. Furthermore, IRF4 was found to bind to IRF8 promoter region ( Figure S2 ), suggesting direct repression of IRF8 by IRF4. The deletion of BCL6 in IRF4 À/À/À cells reduced the expression of BACH2, left IRF8 expression upregulated and PAX5 expression unchanged when compared with WT cells (Figure 1D) . It seems logical that as several PRDM1 downregulators were still expressed, PRDM1 could not be upregulated. Together these findings suggest that DKO cells have not fully adopted the ASC phenotype due to the absence of IRF4 and PRDM1 upregulation.
| Gene expression profiling of BCL6KO, IRF4KO and DKO cells
To take a deeper look into genes regulating the secretory phenotype, we characterized the transcriptome of the DKO and individual knockout cells using a gene expression array. We compared the expression profiles of BCL6KO, IRF4KO and DKO cells relative to WT cells (absolute fold change ≥2, P ≤ .01, Table S1 ). We found that in DKO cells, 546 genes were dependent on BCL6 expression, whereas 837 genes were IRF4-dependent. Approximately 35% of upregulated genes and 31% of downregulated genes in DKO cells were not similarly altered in either one of the single knockout cells (Figure 2A ). Hierarchical clustering (Euclidian distance) of ASC signature genes showed that BCL6KO cells clustered separately from IRF4KO and DKO cells ( Figure 2B ). Gene expression profiles of all of the differentially expressed genes clustered in a similar manner (data not shown). Thus, deletion of both factors together seems to have a unique effect on the gene expression profile.
We then compared gene expression profiles of each knockout cell line with genes of mouse antibody-secreting plasma cells identified previously. 23 The gene expression pattern of BCL6KO cells had the most overlap with the 301 ASC genes ( Figure 2B and Table S2) . 23 This analysis
suggests that DKO cells do not obtain a gene expression profile of ASCs.
To reveal genes regulating the secretory phenotype, we analysed the array data further. We selected the differentially expressed genes from IRF4KO and DKO cells that have not been changed in the same direction in BCL6KO cells (Figure 2A) . We next subtracted genes oppositely regulated (upregulated in BCL6KO and downregulated in IRF4KO and DKO and vice versa) in BCL6KO from IRF4KO and DKO ( Figure 2C dark purple region) . We compared the resulting list of 138 genes ( Figure 2D , Table S3 ) with the list of genes of plasma cell signature 23 and found that only PRDM1 and IRF4 overlapped with it. This verifies independently that BLIMP-1 and IRF4 are both needed for secretory programme. Interestingly, SPI1 was among these 138 genes. The expression of SPI1 was upregulated in IRF4-deficient cells and depleted in antibody-secreting BCL6KO cells ( Figure 2D ).
| BLIMP-1 is insufficient to induce antibody secretion in IRF4KO and DKO cells
The absence of IgM secretion in IRF4-deficient cells could result from the lack of PRDM1 expression. To test whether PRDM1 expression can overcome the blockade of antibody secretion, we introduced forced expression of BLIMP-1 in the IRF4-deficient cells (IRF4KO and DKO). We expressed BLIMP-1 from a lentiviral vector B1-GFP that produces a BLIMP-1-GFP fusion protein ( Figure 3A) in WT, IRF4KO and DKO cells. As a parallel approach validating the functionality of BLIMP-1-GFP fusion protein, we generated another BLIMP-1 expression construct that did not produce potentially interfering fusion partner. This construct codes for a BLIMP1-T2A-GFP fusion protein (B1-T2A-GFP) where T2A self-cleaving peptide mediates the cleavage of BLIMP-1 and GFP during translation (Figure S3A ) yielding two separate proteins: BLIMP-1 and GFP. B1-GFP, B1-T2A-GFP and mock (GFP mock) transduced cells were sorted for GFP expression and expression of PRDM1 (from endogenous and lentiviral sources) was measured by RT-qPCR ( Figure 3B and Figure S3B ). We chose cell populations that had substantial overexpression of PRDM1 to make sure the PRDM1 expression was not the limiting factor for antibody secretion in further analysis.
Overexpression of BLIMP-1 in WT cells (both WT/B1-GFP and WT/B1-T2A-GFP) induced a robust IgM secretion ( Figure 3C and Figure S3C) as expected of functional BLIMP-1 overexpression. However, overexpression of BLIMP-1 in IRF4KO (IRF4/B1-GFP) or DKO (DKO/B1-GFP) cells did not increase IgM secretion when compared to mock-transduced cells ( Figure 3C and Figure S4 ). The increased secretion was accompanied by a increased transcript levels of secretory (lS) form of l heavy chain in BLIMP-1-transduced cell lines ( Figure 3D ). These data suggest that in addition to BLIMP-1, IRF4 plays an essential role in the pathway leading to a secretory phenotype. Given that transcription factors PAX5, BCL6, IRF8 and BACH2 are downregulated in ASCs, 1,2 we also analysed their expression. Despite the enforced BLIMP-1 expression, the expression of PAX5, BACH2 and IRF8 was unaltered in all of the PRDM1-transduced cell lines ( Figure 3D ,E). We also analysed the expression levels of EBF1, SPI1 (encoding PU.1) that are downregulated in ASCs 23 as well as in BCL6KO cells (Table S1 and Figure S3F ). The expression of EBF1 and SPI1 remained unaltered in PRDM1-transduced IRF4KO and DKO cells. The expression of ELL2, which is highly expressed in BCL6KO cells and is required for post-transcriptional expression switch to a secretory form of IgH, remained unaltered in each BLIMP-1-transduced cell line (Figure 3F) . In antibody-secreting BCL6KO cells, where PRDM1 expression is upregulated (Figure 1D ), the expression of ELL2 was upregulated ( Figure 3E ). The only difference we observed with PRDM1 overexpression was the reduction in SPI1 and the surprising reduction in IRF4 expression ( Figure 3E,F) . Together these results indicate that BLIMP-1 is incapable of suppressing B cell phenotype and promoting antibody secretion in the absence of IRF4.
| Enforced IRF4 expression in DKO cells induces IgM secretion
To clarify our observation that IRF4 has a major contribution to antibody secretion, we expressed IRF4 in knockout cell lines. We made a lentiviral vector where the IRF4 expression cassette has a T2A excision sequence between the IRF4 encoding sequence and mCherry (mC) fluorescence marker-encoding sequence (IRF4 mc ) ( Figure 4A ). The expression constructs IRF4 mc and the mock control vector (mC Mock) were introduced into the WT, IRF4KO and DKO cells similarly to PRDM1 expression vector before. We verified that IRF4 was overexpressed in IRF4KO/IRF4 mC and DKO/IRF4 mC cells using RT-qPCR and Western blot ( Figure 4B,D) . In contrast to the enforced BLIMP-1 expression in IRF4KO and DKO cells ( Figure 3B,C) , the overexpression of IRF4 resulted in a moderate increase of IgM secretion in IRF4KO (IRF4KO/IRF4 mC ) cells but in a strong increase in DKO (DKO/IRF4 mC ) cells ( Figure 4C ). This is in line with increased transcript levels of secretory form of l heavy chain ( Figure 4D ). This result indicates that IRF4 promotes antibody secretion especially in the absence of BCL6.
To characterize the gene expression changes in IRF4-transduced cell lines, we analysed the expression levels of IRF4, PRDM1, ELL2, EBF1, IRF8, SPI1, BACH2, BCL6 and PAX5 by RT-qPCR analysis. IRF4 overexpression was able to induce PRDM1 expression only in DKO/IRF4 mC cells ( Figure 4D ). In accordance with ASC phenotype of DKO/IRF4 mc cells, also the expression of PAX5, EBF1, IRF8, SPI1 and BACH2 were downregulated in these cells ( Figure 4E) . Surprisingly, IRF4 overexpression in WT and IRF4KO cells was unable to induce PRDM1 expression or consequent downregulation of B cell identity genes (PAX5, BCL6, EBF1, IRF8, SPI1 and BACH2) suggesting that BCL6 has a major role in the regulation of these genes. The expression of ELL2, however, remained unaltered. SPI1 and IRF8 expressions were increased with IRF4 overexpression in WT but not in IRF4KO cells. On the contrary, BCL6 and BACH2 showed increased expression with IRF4 overexpression in IRF4KO and showed the same trend in WT background, although the difference did not reach statistical significance. Together, these results indicate that both IRF4 and BLIMP-1 are non-redundant for the antibody secretion. Furthermore, IRF4 can induce BLIMP-1 expression and consequent downregulation of B cell identity genes only in the absence of BCL6.
| DISCUSSION
Our data indicate that IRF4 together with BLIMP-1 is needed to induce antibody secretion in DT40 B cells. Ectopic expression of BLIMP-1 in mature B cells can induce maturation into immunoglobulin-secreting cells. 24 However,
here, we demonstrate that ectopic BLIMP-1 expression is insufficient to induce secretion when IRF4 is not present as well as that IRF4 can induce robust secretion only in the absence of BCL6 ( Figure S5 ). BLIMP-1 is the key factor upregulating genes needed for antibody secretion. 12, 13 25 showed that in activated B cells IRF4 in high doses inhibits IRF8 expression and also directly represses BACH2, SPIB, and EBF1.
SPIB is not present in the chicken genome, is highly related to SPI1 and both have a complementary function in B cells 26, 27 and it is plausible that SPI1 fulfils the function of SPIB in chicken B cells. Furthermore, the downregulation of SPIB in ASCs is among the plasma cell signature. 23 Similarly, SPI1 was not expressed in antibody-secreting chicken BCL6KO cells. Moreover, BLIMP-1-induced Ig secretion in DT40 cells occurred only when IRF4 was present and SPI1 expression downregulated. IRF4 has a dual role during germinal centre formation and induction of plasma cell differentiation. IRF4 is required for GC formation via upregulation of BCL6 and OBF1. 10 On the other hand, a high expression of IRF4 is needed for the induction of BLIMP-1 and ASC differentiation as well as for the downregulation of BCL6. 9, 28 The difference in the regulatory outcome is due to the selection of different targets based on IRF4 concentration and involvement of cofactors. High-affinity binding of IRF4 together with PU.1 to EICE motif regulates genes during B cell activation and GC formation, whereas at high doses, IRF4 can bind alone to low-affinity ISRE motif present in PRDM1 inducing the ASC differentiation. 10 Here, we showed that SPI1 (the gene-encoding PU.1) is upregulated in IRF4-deficient cells (IRFKO and DKO). This suggests at least two mutually non-exclusive options: the B cell programme is upregulated in the absence of IRF4 or the cells try to compensate for the loss of IRF4 by upregulating IRF8 and SPI1. IRF8 together with PU.1 is known to repress plasma cell differentiation via modulation of BCL6 expression. 21, 29 Recently, it has been shown that downregulation of ID3 expression is essential for antigen-induced B cell differentiation into plasma cells. 13, 23, 30 As seen in microarray results (Table S1 ) and Figure S6 , the expression of ID3 is significantly downregulated in all the knockout cell lines (IRF4KO, DKO and BCL6KO) even in ones that do not secrete. We cannot conclude whether IRF4 or BLIMP-1 downregulate ID3 in secreting cells. However, in nonsecreting cells, ID3 is downregulated in the absence of IRF4 and BLIMP-1. Thus, we conclude that ID3 is not the key factor regulating secretion in this model system. Stability of BACH2 protein has been previously shown to be dependent on BCL6. 31 Our results suggest that BCL6
is also a major factor for maintaining BACH2 transcription since, in cells deficient in BCL6 (BCL6KO and DKO), BACH2 expression drops dramatically and independently of BLIMP-1 action (DKO cells did not express BLIMP1). Hence, BCL6 regulates BACH2 likely through direct binding to BACH2 gene. 4 When BCL6 was present, the overexpression of IRF4 enhanced expression of B-cell factors. This resembles the situation during the initiation of GC reaction 10 and may be due to the fact that in these cells PU.1 was also expressed. The presence of BCL6 might dictate the outcome of IRF4 action, as IRF4 only induced secretion in the absence of BCL6 in DT40 B cells. Therefore, our data support the model in which BCL6 degradation induced by signals from B-cell receptor 32 would need to occur first to change IRF4-binding preference for upregulation of PRDM1 (through low-affinity sites) and consequent initiation of antibody secretion. Expression of IRF4 in DKO cell should restore the BCL6KO phenotype. Indeed, all the transcription factors measured (PAX5, BACH2, IRF8, SPI1, EBF1 and PRDM1) were restored to the level observed in single BCL6KO cells. The only exception was the expression of ELL2 that was not restored. This might be the underlying reason behind the 10-fold lower IgM secretion by DKO/IRF4 mC cells than BCL6KO cells.
Overexpression of PRDM1 did not have any impact on BCL6 and PAX5 expression in any of the cell lines tested here. Even though BLIMP-1 is essential for the terminal differentiation of ASCs, 33 the upregulation of BLIMP-1 is not an initiative event and preplasmablasts can develop in the absence of BLIMP-1. 34 In fact, it appears that when B cells differentiate to ASCs, PAX5 is transcriptionally downregulated before BLIMP-1 upregulation. 16, 34 It remains to be solved how PAX5 downregulation is achieved. The absence of BCL6 downregulation in the BLIMP-1 transduced cell lines might seem surprising. However, it was previously observed that human primary B cells with induced BLIMP-1 expression started antibody secretion while having high BCL6 expression. 35 Furthermore, another study found BCL6 not to be regulated by BLIMP-1 despite BLIMP-1 binding to BCL6 enhancers. 12 Thus, the regulation of BCL6 expression seems to be more complex than expected. Taken together, our data support a model in which BCL6 would need to be downregulated before IRF4 expression can induce BLIMP-1 expression and consequent initiation of antibody secretion.
